Shares Magazine
333.00p+1.50 (+0.45%)26 Apr 2024, 15:24
Jump to:
Haleon PLC Fundamentals
| Company Name | Haleon PLC | Last Updated | 2024-04-26 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 9.132 bn | Market Cap | £30.40 bn |
| PE Ratio | 29.34 | Dividend per Share | £0.04 |
| Dividend Yield | 1.81 | Dividend Cover | 2.69 |
| EPS | £0.11 | EPS Growth (%) | 0.05 |
| PEG | 1.69 | DPS Growth (%) | 0 |
| Debt Ratio | 0.2777 | Debt Equity Ratio | 0.5299 |
| Asset Equity Ratio | 2.0357 | Cash Equity Ratio | 0.0594 |
| Quick Ratio | 0.6142 | Current Ratio | 1.04 |
| Price To Book Value | 1.8232 | ROCE | 0 |
Haleon PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Prelim | 2024-03-14 | 2024-05-16 | GBP | 0.0420 | |
| Interim | 2023-08-24 | 2023-10-05 | GBP | 0.0180 | |
| Prelim | 2023-03-16 | 2023-04-27 | GBP | 0.0240 |
Haleon PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £1.90 bn | £1.90 bn | £1.66 bn |
| Intangible Assets | £26.86 bn | £28.44 bn | £27.20 bn |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £29.24 bn | £30.76 bn | £29.20 bn |
| Stocks | £1.41 bn | £1.35 bn | £951.00 m |
| Debtors | £1.86 bn | £1.88 bn | £3.71 bn |
| Cash & Equivalents | £994.00 m | £606.00 m | £347.00 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £34.05 bn | £34.81 bn | £34.45 bn |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £4.64 bn | £4.37 bn | £4.24 bn |
| Creditors after 1 year | £12.69 bn | £13.99 bn | £3.73 bn |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £17.33 bn | £18.36 bn | £7.97 bn |
| Net assets | £16.73 bn | £16.46 bn | £26.48 bn |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £92.00 m | £92.00 m | £1.00 m |
| Share Premium | 0 | 0 | 0 |
| Profit / Loss | £1.63 bn | £1.62 bn | £1.64 bn |
| Other Equity | £16.61 bn | £16.33 bn | £26.36 bn |
| Preference & Minorities | £123.00 m | £126.00 m | £125.00 m |
| Total Capital Employed | £16.73 bn | £16.46 bn | £26.48 bn |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.35 | £0.38 | £0.00 |
| Debt-to-Equity | £0.53 | £0.61 | £0.00 |
| Assets / Equity | 2.0357 | 2.0357 | 2.0357 |
| Cash / Equity | 0.0594 | 0.0594 | 0.0594 |
| EPS | £0.12 | £0.11 | £0.15 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | £2.10 bn | £2.06 bn | £1.36 bn |
| Cashflow before financing | £532.00 m | £8.97 bn | £120.00 m |
| Increase in Cash | £398.00 m | £190.00 m | £87.00 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £11.30 bn | £10.86 bn | £9.54 bn |
| Cost of sales | £4.55 bn | £4.28 bn | £3.60 bn |
| Gross Profit | £6.75 bn | £6.58 bn | £5.95 bn |
| Operating Profit | £2.00 bn | 0 | 0 |
| Pre-Tax profit | £1.63 bn | £1.62 bn | £1.64 bn |
Haleon PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition. |
| Latest Interim Date | 2 Aug 2023 |
| Latest Fiscal Year End Date | 29 Feb 2024 |
Haleon PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2023-12-19 | Mr. Manvinder Singh Banga | Non-Executive Director,Senior Independent Non-Executive Director |
| 2024-03-14 | Mr. Brian James McNamara | Executive Director,Chief Executive Officer |
| 2024-03-14 | Mr. Tobias Hestler | Executive Director,Chief Financial Officer |
Haleon PLC Contact Details
| Company Name | Haleon PLC |
|---|---|
| Address | 980 Great West Road, Brentford, TW8 9GS |
| Telephone | +44 2080475000 |
| Website | https://www.haleon.com |
Haleon PLC Advisors
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Darktrace PLC | 608.80 | 17.76 |
| Natwest Group PLC | 306.13 | 5.63 |
| Watches Of Switzerland Group PLC | 351.60 | 5.21 |
| Ashtead Group PLC | 6,048.60 | 5.01 |
| Travis Perkins PLC | 754.00 | 4.80 |
| Tritax Eurobox PLC | 53.49 | 4.27 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Convatec Group PLC | 261.80 | -5.01 |
| Wh Smith PLC | 1,127.00 | -4.65 |
| Entain PLC | 782.58 | -3.29 |
| Beazley PLC | 643.00 | -2.35 |
| Ocado Group PLC | 354.99 | -2.02 |
| Associated British Foods PLC | 2,633.00 | -1.97 |